We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Springer Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Price data last checked 102 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Product Description The importance of drug resistance in cancer chemotherapy cannot be over stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the development of drug-resistant tumors. In the first volume in the series. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described. In the past 2 years there has been substantial progress in understanding the molecular biology associated with these mechanisms of drug resistance. For the first time we are starting to understand which mechanisms are playing an im portant role in human tumors, and even more importantly, clinical trials have recently been initiated in an effort to reverse specific forms of drug resistance. The purpose of this volume is to describe the new advances, both at the molecular level and in the clinic regarding mechanisms of drug resistance and potential ways this resistance can be circumvented. This volume is focused upon mechanisms of resistance associated with two major classes of anticancer drugs: alkylating agents (including cisplatin) and the natural products (e. g. , adriamycin and vinblastine). The first section of the book describes new insights into the genetic mechanisms associated with drug resistance. Review ' This book contains much valuable information, including an extensive bibliography. As such, it is primarily of value as a reference text both for clinical and basic scientific research staff. ' Journal of the National Cancer Institute 84:22 1992 'This book would be a helpful text for basic researchers, clinical investigators, and medical housestaff. It is well written and can be read in a relatively short period of time. ' Breast Cancer Research and Treatment 19 1991
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1461367263
- Domain
- Amazon UK
- Publication Date
- 05 November 2012
- Listed Since
- 03 March 2013
Barcode
No barcode data available
Similar Products You Might Like
99% match
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Springer
£165.95
09 Apr 2026
96% match
Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)
Springer
£149.64
14 Apr 2026
95% match
Cancer Drug Resistance (Cancer Drug Discovery and Development)
Humana
£154.49
13 Jan 2026
95% match
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
Humana
£104.04
19 Apr 2026
95% match
Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)
Humana
£72.83
08 Mar 2026
95% match
Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)
Humana
£84.08
18 Feb 2026
95% match
Drug Resistance in Cancer Cells
Springer
£107.73
08 Apr 2026
95% match
Springer - Molecular Mechanisms of Tumor Cell Resistance
Springer
£93.87
19 Apr 2026
95% match
Progress in Cancer Drug Resistance Research
£97.27
09 Mar 2026
95% match
Springer - Therapeutic Resistance to Anti-hormonal Drugs Book
Springer
£113.78
14 Apr 2026
95% match
Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1
Springer
£184.00
12 Jan 2026
95% match
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
Humana
£87.47
24 Feb 2026
94% match
Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)
£69.58
07 Mar 2026
94% match
Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)
Academic Press
£113.12
13 Jan 2026
94% match
Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)
Humana
£102.99
04 Apr 2026
94% match
Molecular Oncology: Underlying Mechanisms and Translational Advancements
Springer
£82.73
09 Mar 2026
94% match
Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)
Humana
£149.75
13 Jan 2026
94% match
Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)
Humana
£80.39
07 Apr 2026
94% match
Resistance to Targeted ABC Transporters in Cancer: 4 (Resistance to Targeted Anti-Cancer Therapeutics)
Springer
£89.99
13 Apr 2026
94% match
Cancer Drug Resistance (Cancer Drug Discovery and Development)
Humana
£35.15
13 Jan 2026
94% match
Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
Springer
£150.48
06 Mar 2026
94% match
Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)
Springer
£174.62
22 Jan 2026
94% match
Chemistry and Pharmacology of Anticancer Drugs
CRC Press
£192.76
17 Apr 2026
94% match
CRC Press - Chemistry and Pharmacology of Anticancer Drugs
CRC Press
£133.99
15 Apr 2026